UY36676A - Formulación de hidrogel con adhesión moderada - Google Patents
Formulación de hidrogel con adhesión moderadaInfo
- Publication number
- UY36676A UY36676A UY0001036676A UY36676A UY36676A UY 36676 A UY36676 A UY 36676A UY 0001036676 A UY0001036676 A UY 0001036676A UY 36676 A UY36676 A UY 36676A UY 36676 A UY36676 A UY 36676A
- Authority
- UY
- Uruguay
- Prior art keywords
- moderated
- hydrogel
- formulation
- adhesion
- nipple
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000017 hydrogel Substances 0.000 title 1
- 210000002445 nipple Anatomy 0.000 abstract 3
- 230000004888 barrier function Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nanotechnology (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
La presente descripción se refiere a métodos, composiciones y dispositivos para los tratamientos relacionados con el tejido mamario en sujetos, que incluyen la reducción de la incidencia de mastitis. En particular, la descripción se puede referir a la creación de una barrera física en una superficie del pezón, en un canal del pezón, o en una cisterna del pezón para el tratamiento profiláctico de los trastornos mamarios.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562157627P | 2015-05-06 | 2015-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36676A true UY36676A (es) | 2016-12-30 |
Family
ID=56027205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036676A UY36676A (es) | 2015-05-06 | 2016-05-06 | Formulación de hidrogel con adhesión moderada |
Country Status (14)
Country | Link |
---|---|
US (2) | US9987362B2 (es) |
EP (1) | EP3291820B1 (es) |
CN (1) | CN107530277A (es) |
AR (1) | AR104541A1 (es) |
AU (1) | AU2016256858B2 (es) |
BR (1) | BR112017023841B1 (es) |
CA (2) | CA3077942C (es) |
CL (1) | CL2017002801A1 (es) |
ES (1) | ES2949838T3 (es) |
MX (1) | MX370083B (es) |
PL (1) | PL3291820T3 (es) |
RU (1) | RU2693041C2 (es) |
UY (1) | UY36676A (es) |
WO (1) | WO2016179379A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018213433A1 (en) * | 2017-05-16 | 2018-11-22 | Biocure, Inc. | Hydrogel medical adhesives |
EP3700465A4 (en) * | 2017-10-23 | 2021-08-18 | Endologix LLC | ENDOLUMINAL AND POLYMER DEVICE |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4113854A (en) | 1977-01-10 | 1978-09-12 | Minnesota Mining And Manufacturing Company | Prophylactic treatment of mastitis |
US4434181A (en) * | 1981-12-07 | 1984-02-28 | Fearing Manufacturing Co., Inc. | Teat dip |
US5017369A (en) * | 1987-03-03 | 1991-05-21 | Marhevka Virginia C | Film-forming teat sealer for prevention of mastitis and use thereof |
DE3934743A1 (de) | 1989-10-18 | 1991-04-25 | Eckold Vorrichtung | Verfahren zum verbinden zweier bauteile |
TW272976B (es) | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
US5665840A (en) | 1994-11-18 | 1997-09-09 | Novartis Corporation | Polymeric networks from water-soluble prepolymers |
DE69629010T2 (de) | 1995-01-16 | 2004-04-15 | Baxter International Inc., Deerfield | Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen |
TW349967B (en) | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
US5849841A (en) | 1995-02-03 | 1998-12-15 | Ciba Vision Corporation | Crosslinked polymers containing ester or amide groups |
AU4438696A (en) | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers |
TW360671B (en) | 1995-02-03 | 1999-06-11 | Novartis Ag | Process for producing mold body and the cross-linkable polymer used therein |
EP0807269B1 (en) | 1995-02-03 | 1999-10-20 | Novartis AG | Crosslinkable polymers containing photoinitiators |
ATE336307T1 (de) | 1995-12-08 | 2006-09-15 | Novartis Pharma Gmbh | Plasmainduzierte polymere beschichtungen |
US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
US5819988A (en) | 1997-04-01 | 1998-10-13 | Sawhney; Ravi K. | Double-barreled syringe with detachable locking mixing tip |
US6395289B1 (en) * | 1998-06-29 | 2002-05-28 | Hydromer, Inc. | Hydrophilic polymer blends used to prevent cow skin infections |
CA2345018A1 (en) * | 1998-09-21 | 2000-03-30 | 21St Century Medicine, Inc. | Polyvinyl alcohol compounds for inhibition of ice growth |
US6652883B2 (en) | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
ES2253360T3 (es) * | 2000-03-13 | 2006-06-01 | Biocure, Inc. | Articulos biomedicos a base de hidrogel. |
AU4566001A (en) | 2000-03-13 | 2001-09-24 | Biocure Inc | Embolic compositions |
US20020122771A1 (en) | 2000-09-23 | 2002-09-05 | Troy Holland | Spray hydrogel wound dressings |
AU2002334349B2 (en) | 2001-09-10 | 2008-05-15 | Bimeda Research & Development Limited | A bio-security system |
EP1460982A4 (en) | 2001-11-16 | 2010-04-14 | Biocure Inc | METHODS FOR INITIATING IN SITU FORMATION OF HYDROGELS |
CA2472188C (en) * | 2002-01-18 | 2011-06-21 | Control Delivery Systems, Inc. | Polymeric gel system for the controlled delivery of codrugs |
US20060073216A1 (en) * | 2002-12-26 | 2006-04-06 | Solution Biosciences, Inc. | Compositions and methods for control of bovine mastitis |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
JP2006521180A (ja) | 2003-03-25 | 2006-09-21 | バイオキュア・インコーポレーテッド | ヒドロゲル糸による医療装置 |
EP1718237A1 (en) | 2004-02-02 | 2006-11-08 | Bimeda Research And Development Limited | A method and device for treating a teat canal of an animal |
US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
US7235592B2 (en) * | 2004-10-12 | 2007-06-26 | Zimmer Gmbh | PVA hydrogel |
US20070249712A1 (en) * | 2005-02-04 | 2007-10-25 | Dee Alejandro O | Peracetic teat dip |
CN101287454B (zh) * | 2005-10-12 | 2011-07-20 | 兴和株式会社 | 乳腺癌和/或乳腺炎治疗用离子电渗疗法制剂 |
WO2007050744A2 (en) | 2005-10-26 | 2007-05-03 | Biocure, Inc. | Hydrogel spinal disc implants with swellable articles |
WO2008153966A1 (en) | 2007-06-11 | 2008-12-18 | Biocure, Inc. | Mucoadhesive vesicles for drug delivery |
EP2227212A1 (en) | 2007-12-07 | 2010-09-15 | BioCure, Inc. | Bone substitute |
US20090253650A1 (en) * | 2008-04-03 | 2009-10-08 | Pongsamart S | Teat antiseptic prepared from polysaccharide gel with bactericidal and immuno-stimulating activity isolated from durian fruit-rind |
EP2332587A1 (de) * | 2009-12-12 | 2011-06-15 | Bayer MaterialScience AG | Polyurethan-Dispersionen zur Versiegelung von Zitzen der Milchdrüse bei milchliefernden Tieren |
US9232805B2 (en) * | 2010-06-29 | 2016-01-12 | Biocure, Inc. | In-situ forming hydrogel wound dressings containing antimicrobial agents |
CA2840061A1 (en) | 2011-05-27 | 2012-12-06 | Zurex PharmAgra, Inc. | Method of treating a mammalian teat and related compositions |
GB201113606D0 (en) | 2011-08-05 | 2011-09-21 | Norbrook Lab Ltd | Dual chamber syringe |
RU2521401C1 (ru) * | 2012-12-07 | 2014-06-27 | ГНУ Краснодарский научно-исследовательский ветеринарный институт Российская академия сельскохозяйственных наук (Краснодарский НИВИ) | Средство для профилактики мастита у дойных коров в сухостойный период |
CN103275351A (zh) | 2013-05-27 | 2013-09-04 | 山东赛克赛斯药业科技有限公司 | 一种交联剂、交联聚合物及其制备方法与应用 |
AU2014318264B2 (en) | 2013-09-16 | 2018-10-04 | Zoetis Services Llc | Assembly for sequentially delivering substances, and associated methods |
-
2016
- 2016-05-05 CN CN201680026018.6A patent/CN107530277A/zh active Pending
- 2016-05-05 BR BR112017023841-1A patent/BR112017023841B1/pt active IP Right Grant
- 2016-05-05 RU RU2017136861A patent/RU2693041C2/ru active
- 2016-05-05 WO PCT/US2016/030961 patent/WO2016179379A1/en active Application Filing
- 2016-05-05 CA CA3077942A patent/CA3077942C/en active Active
- 2016-05-05 EP EP16724201.5A patent/EP3291820B1/en active Active
- 2016-05-05 US US15/147,530 patent/US9987362B2/en active Active
- 2016-05-05 CA CA2984614A patent/CA2984614C/en active Active
- 2016-05-05 MX MX2017014131A patent/MX370083B/es active IP Right Grant
- 2016-05-05 ES ES16724201T patent/ES2949838T3/es active Active
- 2016-05-05 PL PL16724201.5T patent/PL3291820T3/pl unknown
- 2016-05-05 AU AU2016256858A patent/AU2016256858B2/en active Active
- 2016-05-06 UY UY0001036676A patent/UY36676A/es not_active Application Discontinuation
- 2016-05-06 AR ARP160101295A patent/AR104541A1/es unknown
-
2017
- 2017-11-06 CL CL2017002801A patent/CL2017002801A1/es unknown
-
2018
- 2018-05-04 US US15/971,650 patent/US10449255B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BR112017023841B1 (pt) | 2023-04-18 |
BR112017023841A2 (pt) | 2018-07-31 |
PL3291820T3 (pl) | 2023-08-21 |
WO2016179379A1 (en) | 2016-11-10 |
US20160324969A1 (en) | 2016-11-10 |
MX2017014131A (es) | 2018-03-15 |
MX370083B (es) | 2019-11-29 |
AU2016256858A1 (en) | 2017-11-02 |
CA2984614C (en) | 2020-07-14 |
AR104541A1 (es) | 2017-07-26 |
RU2693041C2 (ru) | 2019-07-01 |
AU2016256858B2 (en) | 2020-10-08 |
US20180264118A1 (en) | 2018-09-20 |
CA3077942A1 (en) | 2016-11-10 |
CN107530277A (zh) | 2018-01-02 |
US9987362B2 (en) | 2018-06-05 |
EP3291820A1 (en) | 2018-03-14 |
ES2949838T3 (es) | 2023-10-03 |
CA2984614A1 (en) | 2016-11-10 |
EP3291820B1 (en) | 2023-05-24 |
RU2017136861A (ru) | 2019-06-06 |
US10449255B2 (en) | 2019-10-22 |
CA3077942C (en) | 2022-05-10 |
CL2017002801A1 (es) | 2018-05-11 |
RU2017136861A3 (es) | 2019-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019000935A1 (es) | Composición farmacéutica, métodos para tratamiento y usos de la misma. | |
CL2017000317A1 (es) | Terapia adjuntiva con 25-hidroxi vitamina d | |
CL2016002516A1 (es) | “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct | |
CO2017001994A2 (es) | Compuestos activos hacia bromodominios | |
WO2016015001A3 (en) | Combination fluid instillation and negative pressure dressing | |
BR102015017380A2 (pt) | dispositivo para a reticulação do tecido do olho, e, composição farmacêutica | |
NI201400112A (es) | Tratamiento del cáncer con inhibidores tor cinasa | |
UY36703A (es) | Composiciones y métodos para la administración de un polinucleótido en una planta | |
CL2017000050A1 (es) | Terapia de combinación para el cáncer | |
IL280592A (en) | Devices and methods for vaginal treatments | |
CO2018012180A2 (es) | Métodos de tratamiento para enfermedades colestásicas y fibróticas | |
BR112017002354A2 (pt) | artigo absorvente extensível | |
GB2558315A (en) | Patterned surfaces | |
CL2017002801A1 (es) | Formulación de hidrogel con adhesión moderada | |
BR112017004745A2 (pt) | adição a um aplicador médico | |
EP3723629A4 (en) | MEDICAL CAPS, DEVICES FOR PLACING CAPS IN VACUUMS, AND ASSOCIATED KITS AND PROCESSES | |
CR20150567A (es) | Revestimientos reticulados suministrados mediante un balón | |
FR3045392B1 (fr) | Dispositif pour le traitement d'un sujet par combinaison notamment de la lithotherapie, la chromotherapie, la luminotherapie et la musicotherapie | |
AR103636A1 (es) | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol | |
EA201691596A1 (ru) | Составы гепарина для наружного применения | |
CL2018002930A1 (es) | (+)-azasetron para uso en el tratamiento de desórdenes de oído. | |
MA40574A (fr) | Traitement de maladies fibrotiques | |
GB2580531B (en) | Medical device for topical treatments | |
AR115575A1 (es) | Antagonista gremlin-1 para la prevención y tratamiento del cáncer | |
AR110679A1 (es) | Linfocitos infiltrantes remanentes de tumor y métodos de preparación y usos de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20240523 |